1. Home
  2. MTVA vs TOMZ Comparison

MTVA vs TOMZ Comparison

Compare MTVA & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTVA
  • TOMZ
  • Stock Information
  • Founded
  • MTVA 2014
  • TOMZ 1979
  • Country
  • MTVA United States
  • TOMZ United States
  • Employees
  • MTVA N/A
  • TOMZ N/A
  • Industry
  • MTVA
  • TOMZ Diversified Commercial Services
  • Sector
  • MTVA
  • TOMZ Finance
  • Exchange
  • MTVA NYSE
  • TOMZ Nasdaq
  • Market Cap
  • MTVA 18.9M
  • TOMZ 21.0M
  • IPO Year
  • MTVA N/A
  • TOMZ N/A
  • Fundamental
  • Price
  • MTVA $1.95
  • TOMZ $1.13
  • Analyst Decision
  • MTVA Strong Buy
  • TOMZ Strong Buy
  • Analyst Count
  • MTVA 1
  • TOMZ 1
  • Target Price
  • MTVA $12.00
  • TOMZ $3.50
  • AVG Volume (30 Days)
  • MTVA 337.7K
  • TOMZ 347.7K
  • Earning Date
  • MTVA 11-07-2024
  • TOMZ 10-30-2024
  • Dividend Yield
  • MTVA N/A
  • TOMZ N/A
  • EPS Growth
  • MTVA N/A
  • TOMZ N/A
  • EPS
  • MTVA N/A
  • TOMZ N/A
  • Revenue
  • MTVA N/A
  • TOMZ $8,197,404.00
  • Revenue This Year
  • MTVA N/A
  • TOMZ $40.32
  • Revenue Next Year
  • MTVA N/A
  • TOMZ $38.17
  • P/E Ratio
  • MTVA N/A
  • TOMZ N/A
  • Revenue Growth
  • MTVA N/A
  • TOMZ N/A
  • 52 Week Low
  • MTVA $1.51
  • TOMZ $0.52
  • 52 Week High
  • MTVA $6.75
  • TOMZ $1.17
  • Technical
  • Relative Strength Index (RSI)
  • MTVA N/A
  • TOMZ 68.59
  • Support Level
  • MTVA N/A
  • TOMZ $1.01
  • Resistance Level
  • MTVA N/A
  • TOMZ $1.14
  • Average True Range (ATR)
  • MTVA 0.00
  • TOMZ 0.09
  • MACD
  • MTVA 0.00
  • TOMZ 0.01
  • Stochastic Oscillator
  • MTVA 0.00
  • TOMZ 83.16

About MTVA METAVIA INC

MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a bacteria decontamination and infectious disease control company, providing environmental solutions for indoor surface decontamination through the manufacturing, sales, service and licensing of its SteraMist brand of products, including SteraMist BIT, a low percentage (7.8%) hydrogen peroxide-based fog or mist that uses Binary Ionization Technology (BIT). Its product portfolio includes SteraMist Surface Unit; SteraMist Environment System; The SteraMist Total Disinfection Cart; SteraMist Select Surface Unit; Stainless Steel 90 Degree Applicator; iHP Plasma Decontamination Chamber; SteraMist Custom Engineered System (CES); and iHP Corporate Service Decontamination.

Share on Social Networks: